Symptomatic cytomegalovirus (CMV) infections are rare in patients with no previous history of immunosuppressive therapy or condition. A 33-year-old woman with type-2 diabetes, endstage renal disease (ESRD) and unexplained lower extremity weakness was admitted with failure to thrive, ongoing hemolysis, low haptoglobin and C3 levels and suppressed IgM and IgG globulin fractions. Multiple cultures and serologic workup for autoimmune disorders remained negative. CMV viral titer by serum polymerase chain reaction (PCR) revealed massive elevation at 9.2 million copies/mL. Initial CMV IgG titer was positive, IgM titer remained consistently negative and CMV was recovered from cerebrospinal fluid, as well. She received treatment with I.V. ganciclovir, CMV immune globulin (CytoGam) and three sessions of plasmapheresis (PLEX). The extreme viremia without neutropenia, lack of IgM antibody reconversion and CMV-mediated hemolysis with a low complement level were all very unusual features. Timely initiation of PLEX may have contributed to recovery.
Introduction
Symptomatic cytomegalovirus (CMV) reactivations are relatively common event in immunosuppressed patients. Typical scenarios would entail severe and prolonged critical illnesses (1) (2) (3) , organ transplant recipients, advanced human immunodeficiency virus (HIV) infections or otherwise immunosuppressed states. A low white blood cell count is an important clinical clue to the diagnosis in organ transplant recipients. Nonetheless, reports continue to emerge documenting atypical, vasculitis-like presentations of CMV infections in formerly healthy, non-immunosuppressed individuals (4) . Other reports are also suggesting that acute kidney injury requiring renal replacement therapy (5) or end-stage renal disease (ESRD) (6) are also predisposing conditions for systemic CMV reactivation. We report an atypical case of CMV reactivation in an ESRD patient with multiple systemic complications.
Case Presentation
A 33-year old African-American woman presented to the emergency department with mental status changes, syncope and hypotension. For several days prior to admission, she experienced increasing weakness and diarrhea. Her past medical history included type-1 diabetic mellitus with diabetic retinopathy, neuropathy and nephropathy. ESRD was declared four months earlier and she has been receiving maintenance dialysis via a right internal jugular tunneled hemodialysis catheter ever since. She has been experiencing an unexplained bilateral lower extremity weakness and was unable to ambulate since ESRD was declared. She was anemic on arrival (hemoglobin; 6.8 g/dL) and had impaired liver function tests (LFT) ( Table 1 ) as well as low serum albumin for months before presentation (2.6-1.2 g/dL). Initially, she was thought to be septic but all cultures, including blood, stool and urine returned negative. The physical exam was remarkable for moderate dependent edemas, abdominal distension and profound lower extremity weakness with maintained sensation. Initial differential of elevated LFTs included drug-induced liver injury which failed to improve upon stopping offending agents. She had persisting, occult blood-positive diarrhea but Clostridium difficile testing carried out by polymerase chain reaction (PCR) was negative on three consecutive occasions. Hemolytic work-up revealed hemolytic anemia with thrombocytopenia and elevated lactate dehydrogenase, low haptoglobin level and a mildly positive coombs reaction ( Figure 1A-B) . Furthermore, she had low C3 and CH50 values with low fibrinogen and D-dimer, raising concern for disseminated intravascular coagulation (DIC) ( , with CD4:CD8 ratio 1.14-1.3. While the peripheral blood smear revealed a "moderate" amount of schistocyte formation, the ADAMTS-13 activity was not suppressed. CT scan of the abdomen revealed diffuse wall thickening and edemas in the entire colon without distention, "most suspicious for infectious and noninfectious colitis, including C. difficile/pseudomembranous colitis. " A bone marrow biopsy recovered normocellular marrow with tri-lineage hematopoiesis and no evidence of hemophagocytosis. For coagulopathy, she received aggressive support, including packed red blood cells and multiple other blood products ( Figure 1C-D) . Given the context of chronic unexplained failure to thrive, persistently low albumin, chronic diarrhea and elevated liver enzymes, a CMV virus PCR plasma titer was obtained with markedly abnormal results (9 200 000 million copies/mL), consistent upon multiple repeats (2 600 000-1 600 000 copies/mL, both from plasma and serum). We felt that the patient's illness represented a truly life-threatening systemic CMV infection with specific involvement of the colon, esophagus and liver strongly suspected; additionally, CNS involvement was strongly suspected due to the lower extremity weakness the patient experienced upon admission. A CMV-specific therapy was instituted both with I.V. ganciclovir and CMV immune globulin (CytoGam). Additionally, in the context of a profound systemic illness, coagulopathy and hemolysis with low complement levels and favorable results on sporadic reports in the past (7, 8) , we elected to institute plasma exchange (PLEX) treatments with a centrifugal system, exchanging x1.5 predicted plasma volume with fresh frozen plasma. The clinical picture of septic shock and DIC resolved after three rounds of PLEX. Her subsequent hospital course was complicated by a new onset left facial drop and left eye blindness; lumbar puncture also returned with a CMV-PCR-positive result from the spinal fluid. CNS magnetic resonance imaging revealed parenchymal thickening compatible with both infectious process and meningitis but there was no evident stigmata of a stroke. She gradually improved, including with decline of serum CMV PCR titers (Table 1) and was discharged to a rehabilitation facility on continued maintenance hemodialysis.
Discussion
CMV can infect multiple cells including endothelial cells, epithelial cells, smooth muscle cells, fibroblasts, leukocytes, as well as retinal and dendritic cells. An intact adaptive immune response to CMV requires both humoral and cellular immunity which helps in controlling the infection once the virus enters latency and prevents 
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This study did not receive any research funding. First of all, the most atypical feature of our current case was the enormous elevation of the CMV viral titer by PCR, in the absence of qualifying immunosuppressive condition. In fact, this marked elevation of viral PCR was unseen by any us before in our career. She had no history of childhood illnesses, recurrent infections or other stigmata of preexisting immune deficiency before the current illness. The elevated CMV PCR titer was repeatedly demonstrated, both from serum and plasma and declined appropriately upon improvement of the patient's condition. She had a preserved her WBC count, thus her presentation was very different from what we would encounter in solid organ transplant recipients. This preserved WBC count may have contributed to the extremes of viral copy number, as the virus is an intracellular pathogen and multiply in mononuclear cells. PLEX removes all subcellular structures and conceivably some of the virus-antibody immune complexes (initial viral PCR titer in plasma: 9 200 000 copy/mL versus serum: 2 600 000 copy/mL), presumably contributing to the decrease of viral load and improvement in the hemolytic processes both. Similarly, the clinical picture of CMV infection-induced septic shock resolved after three rounds of PLEX and with continued slow veno-venous hemofiltration. It should be noted that PLEX alone may have some benefits for the most critically ill subjects (13) . While her markedly abnormal thyroid function tests could be ascribed to the critical illness alone (14) , we speculate that PLEX -as part of its multi-system support -effectively provided replacement for thyroid hormones as well. Second, her illness was accompanied by a profound immune-mediated complement activation, low platelet counts and consumptive coagulopathy. In cell models, CMV-infected human umbilical vein endothelial cells are known to develop a pro-coagulant phenotype (15) . While red blood cell fragmentation was present on the peripheral smear, our Hematology team doubted hemolytic-uremic syndrome. The positive Coombs reaction was likely representing the absorption of viral particles and immune complexes on the surface of red blood cells. Temporarily, the coagulopathy responded well to the initiation of PLEX and presumably represented the combination of systemic inflammatory reaction and relatively poor liver synthetic function. Only very limited published experience addresses the medical therapy for DIC beyond antiviral and hyper-CMV immunoglobulin. Two of these were published after our index observation in 2016, one utilizing PLEX (7), while another applying antiviral therapy and glucocorticoids alone (16 (12) , contributing to increased susceptibility to infections. The underling etiology and unifying diagnosis for her systemic illness remained unclear until the diagnosis secured by viral PCR. In critically ill patients with consumptive coagulopathy, suppressed complement levels or hemolytic anemia, CMV should be strongly considered in the differential. The absence of mononucleosis-type symptoms is not sufficient to rule out the diagnosis on clinical grounds. Our case demonstrated that CMV viral load measurement was more helpful for recognizing systemic CMV reactivation than obtaining CMV-specific IgM antibodies.
Conclusion
In summary, severe CMV disease should be on the differential of malnourished, chronically ill patients presenting with an unexplained systemic illness.
